-
-
-
SUS Environment Has Successfully Commissioned the World's Highest-altitude Waste-to-energy Plant
Lhasa,China,Dec. 17,2024--Lhasa,one of the world\'s highest-altitude cities,poses challenges to waste incineration technologies and equipment performance due to its low temperature and oxygen levels.
-
-
-
-
DPC Dash - Domino's Pizza China Wins Seven-Star Award for Outstanding Contributions in Food Safety & Public Health for the Fourth Year
HONG KONG,Dec. 17,2024-- DPC Dash – Domino\'s Pizza China ("DPC Dash" or the "Company") (1405.HK),the exclusive master franchisee for Domino\'s Pizza in the China Mainland,the Ho
-
-
-
-
MoonFox Analysis | Online Travel Platforms Empower Double 11 Shopping Festival, "Competing" to Drive Growth and New Trends
About us: Aurora Mobile (NASDAQ: JG) established in 2011,is a leading customer engagement and marketing technology service provider in China. Its business includes notification services,marketing grow
-
-
-
-
aiMotive and Safran collaborate to make ADAS & AD development safer
MOUNTAIN VIEW,Calif.,Dec. 17,2024-- aiMotive,a leading provider of cutting-edge simulation and AI technologies,has joined forces with Safran Electronics & Defense to advance the testing and valid
-
-
-
-
Multiplier Taps Industry Leaders from Nium and Paycor to Accelerate Growth
NEW YORK,Dec. 17,2024-- Multiplier,a leading global employment platform,announced today the appointments of Pratik Gandhi as Managing Director and Chief Operating Officer (MD & COO) and Matt Carr
-
-
-
-
Hyundai Mobis Tackles Electric Vehicle Battery Overheating with its New Material Technology
SEOUL,South Korea,Dec. 18,2024-- HyundaiMobis (KRX 012330) announced on 18th that it has developed a new battery cell cooling material to prevent battery overheating during ultra-fast charging of ele
-
-
-
-
Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients
SHANGHAI,Dec. 18,2024-- Everest Medicines (HKEX 1952.HK,"Everest",or the "Company"),a biopharmaceutical company focused on the discovery,clinical development,manufacturing and comm
-
-
-
-
Neurizon Files IND Application to Support HEALEY ALS Platform Trial
Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001
-
-
-
-
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA,an international phase III study being conducted across multiple countries,combines elacestrant with everolimus to treat advanced ER+/HER2- breast cancer with ESR1 mutations,aiming to delay dis
-
-
-
-
2024 SABCS｜Results Unveiled for the Phase III Study of Disitamab Vedotin in Treating HER2-Positive Advanced Breast Cancer with Liver Metastasis
YANTAI,China,Dec. 13,2024-- On the morning of December 12,2024 (UTC-6),at the Poster Spotlight Session "Novel HER2 Therapeutics" of the 47th San Antonio Breast Cancer Symposium (SABCS),Reme
RemeGen Co., Ltd / 12-18
-
Business
